Allergan reaction: Teva meets banks for jumbo $34bn M&A financing
Teva, the New York-listed Israeli pharmaceutical company, held a meeting with banks on Wednesday for the syndication of $33.75bn of loans to buy generic drug business Allergan Generics.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: